Sign in
Back
Su1773 ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY
Journal article   Peer reviewed

Su1773 ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY

Peter Bossuyt, Edouard Louis, Krisztina Gecse, Maria T. Abreu, Paolo Gionchetti, David T. Rubin, Elena Marced, Yuri Sanchez Gonzalez, Patrick Hecht, Jasmina Kalabic, …
Gastroenterology (New York, N.Y. 1943), Vol.166(5), pp.S-806-S-807
2024-05-18
DOI: https://doi.org/10.1016/S0016-5085(24)02337-0
Appears in  Miller School of Medicine - Latest Publications

Metrics

3 Record Views

Details